Cingulate Inc. (NASDAQ: CING) Stock Information | RedChip

Cingulate Inc. (NASDAQ: CING)


$4.2200
+0.1200 ( +1.20% ) 196.3K

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Market Data


Open


$4.2200

Previous close


$4.1000

Volume


196.3K

Market cap


$14.87M

Day range


$4.1300 - $4.9700

52 week range


$1.8001 - $152.4000

SEC Filings


Form Type Description Pages Date
8-k 8K-related 15 Feb 26, 2024
3 Insider transactions 2 Feb 14, 2024
3 Insider transactions 2 Feb 14, 2024
3 Insider transactions 2 Feb 14, 2024
8-k 8K-related 16 Feb 13, 2024
8-k 8K-related 24 Feb 07, 2024
4 Insider transactions 1 Jan 29, 2024
8-k 8K-related 20 Jan 29, 2024
4 Insider transactions 1 Jan 02, 2024
8-k 8K-related 13 Dec 28, 2023

Latest News